Expanding the reach of commercial cell therapies requires changes at medical centers
Abstract The clinical application of cell therapies is becoming increasingly important for the treatment of cancer, congenital immune deficiencies, and hemoglobinopathies. These therapies have been primarily manufactured and used at academic medical centers. However, cell therapies are now increasin...
Main Authors: | David F. Stroncek, Nan Zhang, Jiaqiang Ren, Rob Somerville, Anh Dinh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-04966-6 |
Similar Items
-
The need for uniform and coordinated practices involving centrally manufactured cell therapies
by: David Stroncek, et al.
Published: (2022-04-01) -
Flaxseed (<em>Linum Usitatissimum</em> L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study
by: Dominika Kanikowska, et al.
Published: (2020-04-01) -
Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
by: Alvise Sernicola, et al.
Published: (2022-10-01) -
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: a modern view of the method (review of literature)
by: A. Yu. Polushin, et al.
Published: (2022-05-01) -
Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations
by: Stefan Kayser, et al.
Published: (2020-09-01)